1Grimm W, Rudolph S, Christ M, et al. Prognostic significance of endomyocardial biopsy analysis in patients with idiopathic dilated cardiomvopathy[ J]. Am Heart J, 2003,146(2) : 372-376.
2Constant J. A review of why and how we may use β-blockers in congestive heart failure [ J]. Chest, 1998,113 (3) : 800-808.
3Cice G, Ferrara LD, Andrea A, et al. Carvedilol increase two-year survival in dialysis patients with dilated cardiomyopathy: a prospective,placebo-controlled trial [ J ]. J Am Coil Cardiol, 2003,41 ( 9 ) : 1438-1444.
4Cioffi G, Stefenelli C. Tolerability and clinical effects of carvedilol in patients over 70 years of age with chronic heart failure due to left ven tricular dysfunction [J]. Italian Heart J, 2001,2 [ 12 Suppl] : 1319-1329.
5Palazzuoli A, Bruni F, Puccetti L, et al. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure[J]. Eur J Heart Failure.2002.4(6):785-770.
6Azevedo ER, Kubo T, Mak S, et al. Nonselective versus selective betaadrenergic receptor blocdade in congestive heart failure: differential effects on sympathetic activity [ J ]. Circulation, 2001, 104 ( 18 ) : 2194-2199.
7Hirooka K, Yasumura Y, Ishida Y, et al. Comparative left ventrieular function and neurohumoml effects of chronic treatment with earvedilol versus metoprolol in patients with dilated eardiomyopathy[ J ]. Jpn Circ J,2001,65(11) :931-936.
8Matsumura ST, Tsushima K, Ohtaki E, et al. Effects of carvedilol on plasma levels of IL-6 and TNF- a in nine patients with dilated cardiomyopathy [ J ]. J Cardiol, 2002,39 ( 5 ) : 253-257.
9Lowes BD,Gilbert EM,Abraham WT, et al. Myocardial gene in dilated cardiomyopathy treated with beta-blocking agents[ J]. New Engl J Med,2002,346(18) : 1357-1365.
10Osterziel K J, Ranke MB, Strohm O, et al. The somatotrophic system in patients with dilated cardiomyopthy: relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function[ J]. CIin Endocri, 2000,53( 1 ) :61-68.
